These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3304954)

  • 21. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
    Buchanan MR; Butt RW; Turpie AG
    Am Heart J; 1987 May; 113(5):1133-7. PubMed ID: 2953219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC; Davies JA
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dipyridamole, nifedipine, verapamil, hydralazine and propranolol on the formation of prostacyclin and thromboxane in a coupled system of platelets and aorta.
    Srivastava KC
    Prostaglandins Leukot Med; 1986 Jul; 23(1):31-6. PubMed ID: 3090561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
    Rostagno C; Abbate R; Gensini GF; Coppo M; Prisco D; Boddi M; Neri Serneri GG
    Thromb Res; 1991 Aug; 63(4):457-62. PubMed ID: 1754998
    [No Abstract]   [Full Text] [Related]  

  • 30. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
    Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
    Drugs Exp Clin Res; 1985; 11(9):645-51. PubMed ID: 3939725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal anti-human platelet antibody: a new platelet aggregating substance.
    Higashihara M; Maeda H; Shibata Y; Kume S; Ohashi T
    Blood; 1985 Feb; 65(2):382-91. PubMed ID: 3967086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M; Haslam RJ
    J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A; Davì G; Novo S; Custro N; Mattina A; Gallo V
    Int Angiol; 1985; 4(3):379-82. PubMed ID: 3913716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of gallopamil on platelet aggregation and thromboxane generation.
    Davì G; Novo S; Mattina A; Catalano I; Strano A
    Arzneimittelforschung; 1988 May; 38(5):698-9. PubMed ID: 3415711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
    Jones CR; Pasanisi F; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.